Tirzepatide Lyophilized Powder (10 mg) Tirzepatide (LY3298176) is the first dual-acting agonist that targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors
FPG, fasting plasma glucose;TC, total cholesterol
Ideally, rotate your recipe cycle every one to two weeks to prevent meal fatigue and ensure nutritional variety
It offers a level of weight loss that begins to approach what is seen with bariatric surgery, providing a powerful non-surgical option for eligible patients
Manufactured to our specifications, supplied as a 40mg lyophilised powder in a sterile glass vial, and shipped from UK stock with fast, discreet delivery
Wegovy is actually just a higher dosage of the same active ingredient semaglutide used in Ozempic, which is an injection treatment for type 2 diabetes approved in 2017